)
Dan L. Salain
President & CEO
Recall Therapeutics
Dan is the Co-founder of Recall Therapeutics, Aceragen, Revel Next and Newport Veterinary Group
He has had successful VC fund raises of over $120M from Series A - C. Completed exits in excess of $5B, Aptalis, Aceragen, Graybug, and Iveric Bio combining private sales and IPOs
Led development & Commercialization of products Zenpep, Revel, Zimura, Medidate CD, Lamictal, and Amrix
Sessions
-
23-Jun-2026Theater 4Recall Therapeutics
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}